ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells

Biochemical and Biophysical Research Communications

Volumn 324, Issue 3, 2004, Pages 973-980

  Huang, Chih Yang ^a   Ju Chueh, Pin ^a   Tseng, Chien Tang ^a   Liu, Kuan Yu ^a   Tsai, Hsiao Ya ^a   Kuo, Wei Wen ^a   Chou, Ming Yung ^a   Yang, Jaw Ji ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atrial Natriuretic factor; Cardiomyblast cells; Hypertrophic growth; ZAK

Indexed keywords

ACTIN; ATRIAL NATRIURETIC FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WILD TYPE;

ACTINS; AMINO ACID MOTIFS; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISULFIDES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; IMMUNOPRECIPITATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUCINE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MUTATION; MYOCYTES, CARDIAC; NF-KAPPA B; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RATS; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 5444253276     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.156     Document Type: Article

References (23)

1. E.N. Olson, and M.D. Schneider Sizing up the heart: development redux in disease Genes Dev. 17 2003 1937 1956
2. J.D. Molkentin, and G.W. Dorn II Cytoplasmic signaling pathways that regulate cardiac hypertrophy Annu. Rev. Physiol. 63 2001 391 426
3. P.H. Sugden, and A. Clerk Cellular mechanisms of cardiac hypertrophy J. Mol. Med. 76 1998 725 746
4. M.A. Sussman, A. McCulloch, and T.K. Borg Dance band on the titanic: biomechanical signaling in cardiac hypertrophy Circ. Res. 91 2002 888 898
5. W.R. MacLellan, and M.D. Schneider Genetic dissection of cardiac growth control pathways Annu. Rev. Physiol. 62 2000 289 319
6. Y. Wang, B. Su, V.P. Sah, J.H. Brown, J. Han, and K.R. Chien Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells J. Biol. Chem. 273 1998 5423 5426
7. J. Robbins Remodeling the cardiac sarcomere using transgenesis Annu. Rev. Physiol. 62 2000 261 287
8. J.A. Towbin, and N.E. Bowles The failing heart Nature 415 2002 227 233
9. J.J. Hunter, and K.R. Chien Signaling pathways for cardiac hypertrophy and failure N. Engl. J. Med. 341 1999 1276 1283
10. B. Nadal-Ginard, J. Kajstura, P. Anversa, and A. Leri A matter of life and death: cardiac myocyte apoptosis and regeneration J. Clin. Invest. 111 2003 1457 1459
11. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Myocyte death, growth, and regeneration in cardiac hypertrophy and failure Circ. Res. 92 2003 139 150
12. T.-C. Liu, C.-J. Huang, Y.-C. Chu, C.-C. Wei, C.-C. Chou, M.-Y. Chou, C.-K. Chou, and J.-J. Yang Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif Biochem. Biophy. Res. Commun. 274 2000 811 816
13. J.-J. Yang Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest Biochem. Biophy. Res. Commun. 297 2002 105 110
14. N.H. Purcell, G. Tang, C. Yu, F. Mercurio, J.A. DiDonato, and A. Lin Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes Proc. Natl. Acad. Sci. USA 98 2001 6668 6673
15. T. Minamino, T. Yujiri, N. Terada, G.E. Taffet, L.H. Michael, G.L. Johnson, and M.D. Schneider MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq Proc. Natl. Acad. Sci. USA 99 2002 3866 3871
16. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
17. T. Hunter, and J. Pines Cyclins and cancer II: cyclin D and CDK inhibitors come of age Cell 79 1994 573 582
18. R.C. Braun-Dullaeus, M.J. Mann, A. Ziegler, H.E. von der Leyen, and V.J. Dzau A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II-stimulated vascular smooth muscle cell hypertrophy J. Clin. Invest. 104 1999 815 823
19. T. Monkawa, K. Hiromura, G. Wolf, and S.J. Shankland The hypertrophy effect of transforming growth factor-b is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27 J. Am. Soc. Nephrol. 13 2002 1172 1178
20. J.-M. Li, R.A. Poolman, and G. Brooks Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats Am. J. Physiol. Heart Circ. Physiol. 275 1998 H814 H822
21. G. Wolf, R. Schroeder, G. Zahner, R.A.K. Stahl, and S.J. Shankland High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin-dependent kinases Am. J. Pathol. 158 2001 1091 1100
22. Q. Al-Awqati, and P.A. Preisig Size does matter: will knockout of p21WAF1/CIP1 save the kidney by limiting compensatory renal growth? Proc. Natl. Acad. Sci. USA 96 1999 10551 10553
23. P.A. Preisig, and H.A. Franch Renal epithelial cell hyperplasia and hypertrophy Semin. Nephrol. 15 1995 327 340